BRAVE – 1


Bronchial Sample Collection for a Novel Genomic Test



Adult




See full details

APO-A 1


Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis



Adult




See full details

PFF


Pulmonary Fibrosis Foundation Patient Registry



Adult




See full details

n/a


Reproducibility of Pulmonary Function Tests (PFT) in Patients with Idiopathic Pulmonary Fibrosis (PFTs in IPF)



Adult


This research study is being done because we would like to prove that PFTs are accurate and do not significantly change day to day. Furthermore, we would like to explore the subgroup of PFT results to determine if there are better markers of disease progression in IPF than the ones used commonly.

See full details

203PF203


A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients With Idiopathic Pulmonary Fibrosis



Adult


The purpose of this research study is to evaluate the benefit and safety of the study drug BG00011 compared with placebo in subjects with IPF. BG00011 is an investigation medication which would be self-administered once weekly via subcutaneous injection. Study duration would last for 52 weeks (1 year).

See full details




Study of Clinical Efficacy of Antimicrobial Therapy Strategy Using Pragmatic Design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF)



Adult


The purpose of this research study is to compare the impact of an antimicrobial therapy (co-trimoxazole or doxycycline) strategy plus standard care for IPF versus standard care alone on clinical outcomes in patients diagnosed with IPF. Standard care for IPF may include the use of medications including nintedanib and pirfenidone.

See full details




Validation of the one minute walk test and new respiratory parameters in six minute walk test in patients with Idiopathic Pulmonary Fibrosis



Adult


This research study is being to validate the test performance characteristics and prognostic value of distance walked in a one minute walk test (1MWT) compared to the standard 6MWT in a cohort of patients with IPF as well as healthy control volunteers.

See full details